Candriam S.C.A. Enanta Pharmaceuticals Inc Transaction History

Candriam S.C.A.

$17.1 Billion
Q3 2024

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 12, 2023	SELL	$38.82 - $54.59 $2.33 Million - $3.28 Million	-60,000 Reduced 59.7%	40,507 $1.64 Million
Q3 2022 Nov 10, 2022	SELL	$48.29 - $71.27 $676,060 - $997,780	-14,000 Reduced 12.23%	100,507 $5.21 Million
Q1 2022 May 13, 2022	SELL	$56.06 - $74.11 $2.63 Million - $3.47 Million	-46,851 Reduced 29.04%	114,507 $8.15 Million
Q4 2021 Feb 10, 2022	BUY	$60.19 - $97.37 $9.71 Million - $15.7 Million	161,358 New	161,358 $12.1 Million
Q2 2021 Jul 20, 2021	SELL	$43.76 - $53.11 $7.83 Million - $9.5 Million	-178,941 Closed	0 $0
Q4 2020 Jan 22, 2021	BUY	$41.16 - $47.47 $4.73 Million - $5.45 Million	114,907 Added 179.45%	178,941 $7.53 Million
Q3 2020 Oct 19, 2020	BUY	$43.36 - $53.53 $2.78 Million - $3.43 Million	64,034 New	64,034 $2.93 Million
Q2 2020 Jul 23, 2020	SELL	$46.37 - $57.58 $5.11 Million - $6.34 Million	-110,139 Closed	0 $0
Q4 2019 Jan 21, 2020	SELL	$57.95 - $66.61 $281,694 - $323,791	-4,861 Reduced 4.23%	110,139 $7,000
Q3 2019 Oct 21, 2019	BUY	$60.08 - $88.17 $3 Million - $4.41 Million	50,000 Added 76.92%	115,000 $7,000
Q1 2019 May 02, 2019	BUY	$69.08 - $105.66 $207,240 - $316,980	3,000 Added 4.84%	65,000 $6.21 Million
Q4 2018 Feb 14, 2019	BUY	$65.41 - $84.65 $4.06 Million - $5.25 Million	62,000 New	62,000 $4.39 Million
Q3 2018 Nov 07, 2018	SELL	$85.46 - $126.37 $1.07 Million - $1.58 Million	-12,500 Closed	0 $0
Q2 2018 Aug 14, 2018	SELL	$81.85 - $120.51 $982,199 - $1.45 Million	-12,000 Reduced 48.98%	12,500 $1.45 Million
Q1 2018 May 09, 2018	SELL	$57.91 - $92.15 $2.52 Million - $4.01 Million	-43,500 Reduced 63.97%	24,500 $1.98 Million
Q4 2017 Feb 07, 2018	SELL	$45.65 - $59.37 $7.17 Million - $9.32 Million	-157,000 Reduced 69.78%	68,000 $3.99 Million
Q3 2017 Nov 03, 2017	BUY	$37.91 - $46.8 $8.53 Million - $10.5 Million	225,000	225,000 $10.5 Million

Others Institutions Holding ENTA

# of Institutions

110

Shares Held

21.1M

Call Options Held

4.8K

Put Options Held

4.6K

Farallon Capital Management LLC San Francisco, CA

2.11M
Shares

$18 Million
0.11% of portfolio
Vanguard Group Inc Valley Forge, PA

1.98M
Shares

$17 Million
0.0% of portfolio
Black Rock Inc. New York, NY

1.85M
Shares

$15.8 Million
0.0% of portfolio
Krensavage Asset Management, LLC New York, NY

1.5M
Shares

$12.8 Million
8.7% of portfolio
Morgan Stanley New York, NY

1.1M
Shares

$9.44 Million
0.0% of portfolio

View Full List

About ENANTA PHARMACEUTICALS INC

Ticker ENTA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 20,724,900
Market Cap $177M
Description
Enanta Pharmaceuticals, Inc., a biotechnology company, discovers and develops small molecule drugs for the treatment of viral infections and liver diseases. Its research and development disease targets include respiratory syncytial virus, SARS-CoV-2, human metapneumovirus, and hepatitis B virus. The company has a collaborative development and li...

More about ENTA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Candriam S.C.A., based on Form 13F filings with the SEC.

News

Stay updated on Candriam S.C.A. with notifications on news.

Account